Summary
Pancreatic B-cell function in relation to diabetic retinopathy was studied in 195 NIDDM patients with long-standing diabetes. Background diabetic retinopathy (BDR) was present in 95 (48.7%) and proliferative retinopathy (PDR) in 17 (8.7%) of the subjects. There was no significant difference between the BDR, PDR, and non-retinopathy groups with respect to age, age at diagnosis of diabetes and HbA1 values. Mean duration of diabetes was higher in the PDR group (p<0.05). Serum C-peptide values showed no correlation with the presence of retinopathy or with the duration of diabetes. The C-peptide values were widely scattered in patients with BDR and PDR showing no association between pancreatic B-cell reserve and occurrence or severity of retinopathy in NIDDM patients. Thus, decreased pancreatic B-cell reserve does not appear to be a risk factor for diabetic retinopathy in NIDDM patients.
Similar content being viewed by others
References
Bodansky H. J., Medbak S., Drury P. L., Cudworth A. C.: Plasma C-peptide in long-standing Type I diabetics with and without microvascular disease — Diabète et Métabol.7, 265, 1981.
Burger W., Hövener G., Düsterhus R., Hartmann R., Weber B.: Prevalence and development of retinopathy in children and adolescents with Type I (insulin-dependent) diabetes mellitus. A longitudinal study — Diabetologia29, 17, 1986.
Eff Ch., Faber O., Deckert T.: Persistent insulin secretion, assessed by plasma C-peptide estimation in long-term juvenile diabetics with a low insulin requirement — Diabetologia15, 169, 1978.
Eross J., Kreutzmann D., Jimenez M., Keen R., Rogers S., Colwell C., Vines R., Sillink M.: Colorimetric measurement of glycosylated protein in whole blood, red blood cells, plasma, and dried blood — Ann. clin. Biochem.21, 477, 1984.
Faber O. K., Binder C.: C-peptide response to glucagon. A test for the residual β-cell function in diabetes mellitus — Diabetes26, 605, 1977.
Groop L., Tolppanen E.-M.: Factors influencing beta cell function and insulin sensitivity in patients with Type 2 (non-insulin dependent) diabetes — Acta endocrinol (Kbh.)106, 505, 1984.
Heding L. G.: Radioimmunological determination of human C-peptide in serum — Diabetologia11, 541, 1975.
Kuzuya H., Blix P. M., Horwitz D. L., Steiner D. F., Rubenstein A. H.: Determination of free and total insulin and C-peptide in insulin-treated diabetes — Diabetes26, 22, 1977.
Madsbad S., Faber O. K., Binder C., McNair P., Christiansen C., Transbøl I.: Prevalence of residual beta cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes — Diabetes27 (Suppl. 1), 262, 1978.
Madsbad S., Lauritzen E., Faber O. K., Binder C.: The effect of residual beta cell function on the development of diabetic retinopathy — Diabet. Med.3, 42, 1986.
Mohan V., Ramachandran A., Snehalatha C., Mohan R., Bharani G., Viswanathan M.: High prevalence of maturity onset diabetes of the young (MODY) among Indians. — Diabet. Care8, 371, 1985.
Mohan V., Snehalatha C., Ramachandran A., Jayashree R., Viswanathan M.: Pancreatic beta cell function in tropical pancreatic diabetes — Metabolism32, 1091, 1983.
Mosier M. A.: Circulating C-peptide and diabetic retinopathy — Diabet. Res.1, 151, 1984.
Oakley N., Hill D. W., Joplin G. F., Kohner E. M., Fraser T. R.: Diabetic retinopathy. The assessment of severity and progress by comparison with a set of standard fundus photographs — Diabetologia3, 402, 1967.
Pirart J.: Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 — Diabet. Care1, 168, 1978.
Ramachandran A., Gallaghar T. F., Mohan V., Snehalatha C., Parker C., Ecklund R. E., Shipp J. C., Viswanathan M.: Comparative study of clinical pattern of diabetes from two referral centres for diabetes in the U.S.A. and India — J. diabet. Ass. India26, 83, 1986.
Rendell M.: C-peptide levels as a criterion in treatment of maturity onset diabetes — J. clin. Endocrinol. Metabol.57, 1198, 1983.
Snehalatha C., Ramachandran A., Mohan V., Timothy H., Viswanathan M.: Beta cell function in long-term NIDDM (Type 2) patients and its relation to treatment — Hormone metabol. Res.18, 391, 1986.
Tchobroutsky G.: Relation of diabetic control to development of microvascular complications — Diabetologia15, 143, 1978.
Viswanathan M., Mohan V., Snehalatha C., Ramachandran A.: High prevalence of Type 2 (non-insulin dependent) diabetes among the offspring of conjugal Type 2 diabetic parents in India — Diabetologia28, 907, 1985.
West K. M.: Diabetes in the tropics. Some lessons for Western diabetology. In:Podolsky S., Viswanathan M. (Eds): Secondary diabetes: the spectrum of the diabetic syndromes. Raven Press, New York, 1980; pp. 249.
Who Expert Committee on Diabetes Mellitus. Second Report. Technical Report Series 646, WHO, Geneva, 1980.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Snehalatha, C., Mohan, R., Mohan, V. et al. Pancreatic B-cell function in relation to diabetic retinopathy in Asian Indian NIDDM patients. Acta diabet. lat 25, 95–100 (1988). https://doi.org/10.1007/BF02581372
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02581372